Caribou Biosciences Statistics
NASDAQ: CRBUHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4602-0.021 (-4.36%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Caribou Biosciences by the numbers
Caribou Biosciences has a market capitalization of $49.3 million based on 107.21M shares outstanding. With trailing EPS of $-1.03, Caribou Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 67.8% below its 50-day average and 73.3% below its 200-day average.
Average daily trading volume is 2.14M shares, or about $986,841 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRBU valuation vs. peer median
| Metric | CRBU | Peer median | Difference |
|---|---|---|---|
| Market cap | $49.34M | $48.06M | +3% |
| Avg. volume | 2.14M | 12.88K | +16548% |
Peer median across 8 companies: EXOZ, IMA, BKHA, INMB, BSEM, TIL, LONA, TVGN.
Valuation
- Market cap
- $49.34M
- EPS (TTM)
- $-1.03
- Shares outstanding
- 107.21M
Price and trading
- Previous close
- 0.4812
- Open
- 0.46
- Day range
- 0.4425 – 0.5194
- 52-week range
- 0.4425 – 3.54
- 52-week change
- -83.27%
- Beta
- —
- Volume
- 9.68M
- Average volume
- 2.14M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 49.34M
- Forward Pe
- -0.51
- Eps
- -1.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.54
- Week52 Low
- 0.44
- Avg Volume
- 2.14M
- Shares Outstanding
- 107.21M
- Ma50
- 1.43
- Ma200
- 1.72
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -86.98%
- Pct From52w Low
- 4.00%